N-{(R)-4-[4-(2-Fluoro-6-hydroxy-3-methoxy-benzoyl)-benzylamino]-azepan-3-yl}-isonicotinamide; tri hydrochloride

ID: ALA1202519

Chembl Id: CHEMBL1202519

PubChem CID: 49860222

Max Phase: Preclinical

Molecular Formula: C27H30ClFN4O4

Molecular Weight: 492.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(O)c(C(=O)c2ccc(CN[C@@H]3CCCNC[C@H]3NC(=O)c3ccncc3)cc2)c1F.Cl

Standard InChI:  InChI=1S/C27H29FN4O4.ClH/c1-36-23-9-8-22(33)24(25(23)28)26(34)18-6-4-17(5-7-18)15-31-20-3-2-12-30-16-21(20)32-27(35)19-10-13-29-14-11-19;/h4-11,13-14,20-21,30-31,33H,2-3,12,15-16H2,1H3,(H,32,35);1H/t20-,21-;/m1./s1

Standard InChI Key:  JDJSYZZSMSMJDU-MUCZFFFMSA-N

Associated Targets(Human)

AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PRKACA cAMP-dependent protein kinase A (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 492.55Molecular Weight (Monoisotopic): 492.2173AlogP: 2.81#Rotatable Bonds: 8
Polar Surface Area: 112.58Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 6.54CX Basic pKa: 9.50CX LogP: 2.00CX LogD: 1.85
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.36Np Likeness Score: -0.45

References

1. Breitenlechner CB, Wegge T, Berillon L, Graul K, Marzenell K, Friebe WG, Thomas U, Schumacher R, Huber R, Engh RA, Masjost B..  (2004)  Structure-based optimization of novel azepane derivatives as PKB inhibitors.,  47  (6): [PMID:14998327] [10.1021/jm0310479]

Source